乐普医疗：上半年净利润同比下降0.91% 拟10派1.6275元

Core Viewpoint - Lepu Medical reported a slight decline in revenue and net profit for the first half of 2025, indicating potential challenges in maintaining growth despite a positive performance in its cardiovascular intervention segment [1] Financial Performance - The company achieved operating revenue of 3.369 billion yuan, a year-on-year decrease of 0.43% [1] - The net profit attributable to shareholders was 691 million yuan, down 0.91% year-on-year [1] - Basic earnings per share were reported at 0.3748 yuan [1] Dividend Announcement - The company proposed a cash dividend of 1.6275 yuan per 10 shares (including tax) [1] Business Segment Performance - The cardiovascular intervention business generated operating revenue of 1.239 billion yuan, reflecting a year-on-year growth of 7.57% [1] Financing Plans - The company plans to apply for registration with the China Interbank Market Dealers Association to publicly issue up to 1 billion yuan in medium-term notes in the national interbank bond market [1]